Domestic equities are expected to see inflows to the tune of $250 million (Rs 1,900 crore) on account of the semi-annual rebalancing of the MSCI India Index, which is tracked by funds worth $14 billion (Rs 1 trillon), according to domestic brokerage Emkay Global. The rebalancing is scheduled to take place on May 12, and the changes will become effective from June 1.
According to the brokerage, Tata Consumer, Torrent Pharma, Jubliant Food, and Biocon are key inclusion candidates. These stocks are expected to see inflows in the range between $50 million (Rs 380 crore) and $85 million (Rs 640 crore).